Atlas Trials

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

Clinical trial NCT04577352 · COMPLETED

Trial details

NCT number
NCT04577352
Sponsor
PTC Therapeutics
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Friedreich Ataxia
Start date
2020-12-17
Primary completion
2023-04-04
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.